Diese Veranstaltung hat bereits stattgefunden

Kongress

14th EGS Congress 2020

European Glaucoma Society Congress
1000 Brussels, Belgien
Veranstaltungsnummer: 32220
Zertifizierung: beantragt
Gebühren ab: 220,00 €
verfügbare Plätze: unbegrenzt
Sprache: Deutsch

 Zum Kalender hinzufügen
  • Datum
    14.12.2020, 08:30 - 16.12.2020, 16:45
    Veranstalter
    European Glaucoma Society (EGS)
    Kurzbeschreibung
    The next EGS Congress will be held from May 30 to June 2, 2020 in Brussels, Belgium. In terms of both content and attendance, this Congress is expected to be the largest glaucoma meeting in Europe. We expect that our glaucoma industry colleagues will be pleased by our plans for EGS 2020. The congress will be open to all glaucoma care providers including: glaucoma specialists, general ophthalmologists, optometrists, researchers, nurses, technicians, leaders of glaucoma patient organizations etc.
    Hinweis
    The 14th EGS Congress 2020 will submit the application form in order to be accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists.\r\n\r\nThe EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.\r\n\r\nEACCME credits are recognized by the American Medical Association towards the Physician’s Recognition Award (PRA). To convert EACCME credit to AMA PRA category 1 credit, contact the AMA.
    Gebühren

    Fachärzte

    		 Teilnehmer max.
    unbegrenzt

    Gebühren ab
    850,00 €

    Earlybird bis 28.02.2020
    480,00 €
    		 Hinweis
    FEES - VAT included:

    EGS Members
    Before February 28th , 2020: € 420,00
    From February 29th to April 30th , 2020: € 615,00
    From May 1st 2020 and onsite: € 775,00

    Delegates non members
    Before February 28th , 2020: € 480,00
    From February 29th to April 30th , 2020: € 690,00
    From May 1st 2020 and onsite: € 850,00

    Orthoptisten/-innen

    		 Teilnehmer max.
    unbegrenzt

    Gebühren ab
    500,00 €

    Earlybird bis 28.02.2020
    280,00 €
    		 Hinweis
    FEES - VAT included:

    COT (certified ophthalmic technician), orthoptist, certified nurse
    Before February 28th , 2020: € 280,00
    From February 29th to April 30th , 2020: € 380,00
    From May 1st 2020 and onsite: € 500,00

    Sonstige

    		 Teilnehmer max.
    unbegrenzt

    Gebühren ab
    425,00 €

    Earlybird bis 28.02.2020
    220,00 €
    		 Hinweis
    FEES - VAT included:

    Resident in training(*)
    Delegates in need of financial assistance (^)
    Before February 28th , 2020: € 220,00
    From February 29th to April 30th , 2020: € 315,00
    From May 1st 2020 and onsite: € 425,00

    * Application for the resident fee should be certified by a letter from the head of the department to be up-loaded in the on-line platform directly (pdf format is required), stating that the applicant is an ophthalmology resident at the time of registration.

    ^ Application for special financial assistance must be made in writing to the EGS Secretariat, no later than 15 January 2020.
    Deadlines

    Abstract

    		 15.12.2019 Hinweis
    Call For Abstracts: Do not miss the opportunity to present your work in Brussels! The Call for Abstracts closes on December 15. Please carefully review the following guidelines prior to submitting an abstract. Registration for the Congress is mandatory for presenting authors. The presenting author of an abstract must be registered by March 15, 2020 Abstract Preparation: Experiments and data must be completed at the time of the abstract submission. Abstracts for papers already published or accepted before the 14th EGS congress deadline will not be accepted. Scientific material submitted to the 2019 ARVO meeting are exempted from this rule; however this fact must be clearly indicated in the abstract. The following subdivision of abstract is mandatory: Purpose, Methods, Results, Conclusions. Abstracts lacking a description of study methodology and a quantitative description of data will not be accepted. Abstracts without a topic category indicated will not be reviewed. The Scientific Programme Committee aims for 'to the point' informative abstracts. Extensive presentations overloaded with details should be avoided. Multiple submissions of the same topic on different abstracts will be rejected. The Abstract must be written in English. Rules for abstract submission: Abstracts should be unpublished work at the time of presentation. Abstracts submission is possible on-line through the website only. Abstracts submitted by email, fax or post will not be accepted. The online abstract submission is available from September 30, 2019 through December 15, 2019, 11:00 p.m. local time (CET) on the congress website. Abstract length is limited to 350 words (tables and graphics included). The submitting author creates a personal account with email address and password and can submit, edit or delete abstracts until the submission deadline. At no time the Organizing Secretariat Staff can make any changes to abstracts. An individual may be first author (i.e. presenting author) of only one abstract. The presenting author's name must be the first name on the author’s list. It is permitted to be a co-author of an unlimited number of abstracts. Presenting authors (first authors) are expected to attend the congress and present their poster. Authors who are unable to attend and give the presentation as scheduled, must notify the Organizing Secretariat OIC and withdraw their abstract at abstractEGS@oic.it. All accepted abstracts will be assigned to poster or oral presentation at the discretion of the EGS Scientific Committee. Do not submit an abstract if you do not intend to present it at the Congress. Once programmed, abstract presentation times and locations cannot be changed. The Scientific Committee reserves the right to reject abstracts. All abstracts will be reviewed by the Scientific Committee. The reviewing process is strictly confidential and all reviewers have agreed to the following: "I understand the confidential nature of the abstracts, and I will not discuss their contents with any individual, nor will I make copies of abstracts for my own or others' use. In addition, I will not review any abstracts where conflict of interest may be perceived, i.e., work on which I have authored or co-authored or work completed in laboratories where I work." Note: When selecting an abstract Category, please choose carefully. The abstract Category you select will determine which Scientific Section your abstract will be destined. For abstracts withdrawn after January 15, 2020, the entire abstract will appear in the Congress publications. Full text of all abstracts selected for presentation and publication will be available on the EGS Website from April 20, 2020.

  • Monday December 14th

    08:30 - 09:45
    Session 1
    Welcome to the 40th anniversary of the EGS

    08:40
    08:50

    		 The EGS from 1998 to 2020. Showcases

    08:50
    09:00

    		 New EGS initiatives

    09:00
    09:10

    		 The EGS in Brussels

    09:15
    09:45

    The Jules Francois lecture
    The crucial role of randomized glaucoma trials - and the need for relevant and effective outcome criteria

    09:50 - 11:00
    Session 2

    40 years into the future... 

    09:50
    10:02

    		 Glaucoma diagnostic over the next 40 vears

    10:04
    10:16

    		 Tell me your genome and I´ll tell you about your risk of glaucoma

    10:18
    10:30

    		 The future of medical therapy

    10:32
    10:44

    		 The future of glaucoma surgery

    10:46
    11:00

    		 Discussion

    11:00
    11:50

    		 Poster session
    Rapid fire

    12:00
    13:30

    		 Educational Partner Lunch Symposium

    13:35 - 14:50
    Session 3

    Precision medicine: Beyond signs and symptoms

    13:35
    13:47

    		 Why do we need precision medicine?

    13:49
    14:01

    		 What will be the role of IOP in the era of precision medicine?

    14:03
    14:15

    		 Will optic nerve head biomechanics help personalised management?

    14:17
    14:29

    		 Glaucomics

    14:31
    14:50

    		 Discussion

    15:00
    16:00

    		 EGS Courses I

    16:10
    17:10

    		 EGS Courses II

    17:15
    18:15

    		 EGS Courses III

    18:30 - 20:30

    Welcome reception

     

    Tuesday December 15th

    08:00
    08:30

    		 General Assembly of the EGS

    08:40 - 10:00
    Session 4

    Joint EGS-AGS session: New advances in glaucoma medical therapy

    08:40
    08:52

    		 Unmet needs in medical therapy: The right drug for the right patient

    08:54
    09:06

    		 The US experience with new approved drugs

    09:08
    09:20

    		 New targets for new treatment

    09:22
    09:34

    Doctor, will you be able to restore my vision?

    09:36
    10:00

    Discussion

    10:00
    10:45

    Poster session

    10:50 - 12:00
    Session 5

    Have pivotal studies impacted on my patient´s management?

    10:50
    11:02

    		 The EAGLE and ZAP studies

    11:04
    11:16

    		 Laser versus Medications: The LIGHT Study

    11:18
    11:30

    		 The EMGT and the UKGT Study

    11:32
    11:44

    		 The New EGS Guidelines

    11:45
    12:00

    		 Discussion

    12:10
    13:40

    		 Educational Partner Lunch Symposium

    13:45
    14:45

    		 EGS Courses IV

    15:00 - 16:15
    Session 6

    Is the glaucoma world ready for Artificial Intelligence?

    15:00
    15:12

    		 What do we need to do pave the way for Artificial Intelligence?

    15:14
    15:26

    		 Planning ahead: How to keep up with advancing Artificial Intelligence

    15:28
    15:40

    		 Real World Data and Artficial Intelligence

    15:42
    15:54

    		 Clinics in 40 years from now - humans or robots?

    15:55
    16:15

    		 Discussion

    16:20
    17:20

    		 EGS Courses V

    17:25
    18:15

    		 Poster session
    Rapid fire

    08:00
    09:00

    		 EGS Courses VI

     

    Wednesday December 16th

     

    09:15 - 10:45
    Session 7

    Surgery: Which patient, which intervention and when?

    09:15
    09:36

    Clinical case No. 1
    Clinical case No. 2
    Clinical case No. 3
    Clinical case No. 4

    09:38
    09:50

    		 Can we personalize glaucoma surgery?

    09:52
    10:04

    		 What are risks of surgery today?

    10:06
    10:18

    What is the best initial treatment for patients with qadvanced glaucoma?

    10:20
    10:45

    Audience interaction and discussion

    10:45
    11:30

    Coffee break
    Poster exhibition
    Rapid fire

    11:30 - 12:45
    Session 8

    Have pivotal studies impacted on my patient´s management?

    11:30
    11:42

    		 Can better phenotyping help in earlierer diagnosis of glaucoma?

    11:42
    11:54

    		 Is angle closure in Europe more common than we think?

    11:54
    12:06

    		 Are there lifestyle changes I can suggest to my patient?

    12:06
    12:18

    		 Who should we treat aggresively?

    12:18
    12:30

    		 How do I know wheter I am doing any good to my patients

    12:30
    12:45

    		 Discussion

    13:00
    14:30

    		 Industry sponsored lunch symposium (EGS educational partner)

    14:40 - 16:15
    Session 9

    MIGS: Hype or hope

    14:40
    14:52

    		 Redefining MIGS

    14:54
    15:06

    		 What is driving the use of MIGS?

    15:08
    15:20

    		 Adding MIGS to Phaco: solution or illusion?

    15:22
    15:34

    		 Safety of MIGS: myth and facts

    15:36
    15:48

    		 What have we learned from MIGS?

    15:48
    16:15

    		 Discussion

    16:30

    		 Close of meeting

    16:45

    		 Farewell reception
  • SQUARE Brussels Meeting Centre

    OIC Organizzazione Internazionale Congressi Srl.
    Viale G. Matteotti, 7
    IT - 50121 Florenz
    Tel.: +39 055 50 351
    Fax: +39 (0)55 50 019 12

  • For further information please contact the organizer. 

     

Kontakt

030 / 920 3854 262

info@eyefox.com